Sandoz Group AG | Finanzwire

BRIEF

published on 09/08/2026 at 07:10, 3 days 14 hours ago

Sandoz Boosts Biosimilar Production with New Facility in Slovenia

Investment Capacity Expansion Sandoz Biosimilar Manufacturing Slovenia Facility
PRESS RELEASE

published on 09/08/2026 at 07:05, 3 days 14 hours ago

Sandoz invests in new drug substance facility in Ljubljana, Slovenia, to expand biosimilar manufacturing capacity
Sandoz announces USD 300 million investment in new drug substance facility in Ljubljana, Slovenia, to enhance biosimilar manufacturing capacity and support Bio100 goal

Manufacturing Investment Biosimilar Sandoz Facility
BRIEF

published on 09/08/2026 at 07:05, 3 days 14 hours ago

Sandoz Reveals Bio100 Ambition at Capital Markets Day

Growth Strategy Investor Day EBITDA Margin Biosimilars Bio100
PRESS RELEASE

published on 09/08/2026 at 07:00, 3 days 14 hours ago

Sandoz hosts Capital Markets Day and unveils Bio100 ambition – maximising Sandoz value in its golden decade for biosimilars
Sandoz hosts Capital Markets Day unveiling Bio100 ambition to maximize value in golden decade for biosimilars. Strong growth plan aims for 100+ biosimilars by 2040

Growth Strategy Biosimilars Capital Markets Day Sandoz Bio100 Ambition
BRIEF

published on 08/17/2026 at 02:05, 25 days 19 hours ago

Sandoz and Henlius Forge Major Biosimilar Collaboration

Market Expansion Sandoz Biosimilar Collaboration Henlius Pharmaceutical Pipeline
PRESS RELEASE

published on 08/17/2026 at 02:00, 25 days 19 hours ago

Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, further expanding industry-leading pipeline
Sandoz announces strategic collaboration with Henlius on up to 10 biosimilars, expanding industry-leading pipeline. Agreement includes cetuximab, evolocumab, belimumab biosimilars, and option for human hyaluronidase

Collaboration Biosimilars Pipeline Sandoz Henlius
BRIEF

published on 08/05/2026 at 07:05, 1 month 6 days ago

Sandoz Reports Strong H1 2026 Financial Results

Net Sales Increase Sandoz Group AG Biosimilars Growth H1 2026 Financial Results Core EBITDA Improvement
PRESS RELEASE

published on 08/05/2026 at 07:00, 1 month 6 days ago

Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter
Sandoz delivers strong H1 2026 results, with outstanding biosimilar growth in the second quarter. Company confirms full-year guidance amidst solid financial performance

Financial Performance Guidance Sandoz H1 2026 Results Biosimilar Growth
BRIEF

published on 08/03/2026 at 07:05, 1 month 8 days ago

Sandoz Advances in Resolving US Generic Medicine Litigation

Pharmaceutical Market Legal Resolution Sandoz Settlements US Generic Litigation Antitrust Claims
PRESS RELEASE

published on 08/03/2026 at 07:00, 1 month 8 days ago

Sandoz takes further steps to resolve legacy US generic medicine litigation
Sandoz Group AG announces settlements to resolve US generic medicine litigation with 43 states & territories and indirect resellers, with no impact on financial outlook

Litigation Settlements Financial Outlook Sandoz US Generic Medicine

1 2 ... 7

Published on 09/11/2026 at 17:00, 4 hours 24 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 15:25, 5 hours 59 minutes ago

Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 6 hours 24 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 6 hours 54 minutes ago

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 7 hours 26 minutes ago

BlackBerry Radar Advances Asset Intelligence for Transportation

View all ACCESSWIRE

Published on 09/11/2026 at 19:44, 1 hour 39 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 3 hours 9 minutes ago

CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:07, 3 hours 17 minutes ago

Holding(s) in Company
Published on 09/11/2026 at 18:06, 3 hours 17 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 09/11/2026 at 17:30, 3 hours 54 minutes ago

NAGRAVISION and Plume Strengthen Connected Home Security for 30 Million Subscribers Worldwide

View all EQS

Published on 09/11/2026 at 07:00, 14 hours 24 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 14 hours 24 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 1 day 1 hour ago

Availability of the 2026 Interim Financial Report
Published on 09/10/2026 at 07:00, 1 day 14 hours ago

2026 H1 results and new identity
Published on 09/09/2026 at 18:45, 2 days 2 hours ago

Successful launch of a €500 million bond issue

View all LES ECHOS COMFI WIRE

News